OAKLAND, Calif. — After counsel withdrew for some of the plaintiffs in a huge consolidated legal battle between Gilead Sciences and patients with HIV and AIDS who sued over Gilead’s treatments, which allegedly caused them kidney and bone damage, the pharmaceutical giant moved to dismiss litigants who had not found new counsel or filed to proceed pro se. A California court partially granted the motion and scheduled a case management conference.
Read the ruling here.
Read our prior coverage of this lawsuit here.
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Search Articles
